Compounds > n(delta)-(n-methyl-n-nitrosocarbamoyl)-l-ornithine
Page last updated: 2024-09-02

n(delta)-(n-methyl-n-nitrosocarbamoyl)-l-ornithine and Carcinoma, Anaplastic

n(delta)-(n-methyl-n-nitrosocarbamoyl)-l-ornithine has been researched along with Carcinoma, Anaplastic in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Curphey, TJ; Kuhlmann, ET; Longnecker, DS; Schaeffer, BK1

Other Studies

1 other study(ies) available for n(delta)-(n-methyl-n-nitrosocarbamoyl)-l-ornithine and Carcinoma, Anaplastic

ArticleYear
Experimental induction of pancreatic carcinomas in the hamster with N delta-(N-methyl-N-nitrosocarbamoyl)-L-ornithine.
    Journal of the National Cancer Institute, 1983, Volume: 71, Issue:6

    Topics: Animals; Carcinoma; Cricetinae; DNA, Neoplasm; DNA, Single-Stranded; Dose-Response Relationship, Drug; Female; Male; Nitrosamines; Nitrosourea Compounds; Pancreas; Pancreatic Neoplasms

1983